Assetmark, Inc Artivion, Inc. Transaction History
Assetmark, Inc
- $32.1 Billion
- Q2 2024
A detailed history of Assetmark, Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 1,385 shares of AORT stock, worth $35,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,385
Previous 1,385
-0.0%
Holding current value
$35,663
Previous $29,000
20.69%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AORT
# of Institutions
166Shares Held
35.4MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$171 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$72.4 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$71.9 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$71.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$60.8 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.04B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...